AMGEN INC·4

May 11, 8:17 PM ET

Busch Matthew C. 4

Research Summary

AI-generated summary

Updated

Amgen VP & CAO Matthew Busch Sells 41 Shares for Tax Withholding

What Happened

  • Matthew C. Busch, Vice President, Finance & Chief Accounting Officer of Amgen Inc. (AMGN), had 41 shares disposed on May 7, 2026 to satisfy tax withholding obligations related to equity awards. The shares were priced at $331.11 each for a gross value of about $13,576.

Key Details

  • Transaction date: 2026-05-07
  • Type: Tax withholding / payment of tax liability (Form 4 code F)
  • Shares disposed: 41 at $331.11 per share (total ≈ $13,576)
  • Footnote: 39 of these shares represent Dividend Equivalents credited to unvested Restricted Stock Units under Amgen’s equity plan; DEs are paid in shares on a one-to-one basis per the vesting schedule, with cash for fractional shares.
  • Shares owned after transaction: not disclosed in the provided filing excerpt
  • Filing timeliness: Report filed 2026-05-11 (within the Form 4 two-business-day requirement)

Context

  • This was a routine tax-withholding transaction tied to equity compensation (DEs/RSUs), not an open-market purchase or a discretionary sale for investment purposes. Such withholdings are common when awards vest or dividend equivalents are credited and generally reflect administrative tax obligations rather than a trading signal.